Here are three notes.
1. Analysts gave AmSurg shares a $94.33 price target
2. The shares have a rating of 1.2, indicating a “buy” rating.
3. During the most recent quarter, AmSurg’s earnings per share totaled $1.01.
More articles on surgery centers:
Analysts give SCA a $53.15 price target — 6 notes
CHI St. Luke’s pursues ASC expansion plans in Houston, acquires & rebrands Woodlands Ambulatory Surgery Center — 4 key takeaways
Nobilis shares rally 45.6% in 3 months — 4 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
